Redbiotec AG
Christian Schaub has extensive work experience in various roles and industries. Christian is currently a Board Member at a food brewing company since 2023. Christian has also been a Mentor, Startup Coach, Trainer, and Key Note Speaker at venturelab (IFJ) since 2004. Additionally, Schaub serves as the CEO and President, as well as Chairman of the Board of Directors, at Redbiotec AG since 2006. Christian has lectured on entrepreneurship programs at ETH Zurich since 2003 and at the University of Zurich since 2009. Prior to these roles, Schaub was the Founder and partner at Cognition, Zurich, providing business consulting services to international and Swiss companies and the public sector. Christian also served as the Head of Marketing and Communications at Websemantix AG from 1999 to 2001 and as a Project leader and Consultant for Financial Companies at AWK Group from 1996 to 1999.
Christian Schaub completed their Master of Science (MS) in Information Technology/Electrical Engineering from ETH Zürich from 1990 to 1996. Prior to that, they attended Literargymnasium Rämibühl from 1983 to 1989, although their degree and field of study during that time are not specified.
This person is not in any teams
This person is not in any offices
Redbiotec AG
Redbiotec is a privately held Swiss biopharmaceutical company, based in Zurich-Schlieren. Founded in 2006 as a spin-off of the Swiss Federal Institute of Technology in Zurich (ETH Zurich), the company has won several awards, including the renowned W.A. De Vigier Award. The company is successful in producing key proteins and genetic materials for biopharma and food industry thanks to a dedicated scientific team with expertise in multiple disciplines from immunology and microbial engineering to protein engineering. Presently, Redbiotec is involved in the alternative-dairy development. We are using precise fermentation in different expression platforms to recombinantly produce milk proteins, such as caseins, with high yield and their post-translational modifications. We actively evaluate partnering opportunities with the goal of reinforcing our portfolio, and/or to add value to the process developed by our collaboration partners. We welcome strategic partnerships to use our recombinant proteins for animal-free food products and to increase the impact of our technology platforms.